Skip to content
AnalystLens

CBRE GROUP, INC. 8-K Report, Executive Changes (Dec 8, 2009)

Reports
Leadership Changes·Exhibits & Filings
Filing Date
Filed December 8, 2009
Period End
December 2, 2009
Security
CBRE
In the record · 2016–202610-K1110-Q328-K149

CBRE filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 149 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’17Mar ’17
  2. Leadership change8-K · Apr ’19Apr ’19
  3. Material agreement8-K · Jul ’21Jul ’21
  4. Leadership change8-K · Aug ’25Aug ’25

Summary

Summary of the 8-K filed December 8, 2009. Cited figures are marked; the original filing is the authoritative source.

This Form 8-K filing by CB Richard Ellis Group, Inc. (CBRE) on December 8, 2009, reports two significant events.

The first is the appointment of Dr. Laura D’Andrea Tyson to the company's Board of Directors, effective March 4, 2010. Dr. Tyson's addition to the board could bring valuable strategic insights and external perspective to the company's governance during a dynamic economic period. The second key development is the adoption of a new form of Indemnification Agreement for board members, officers, and certain subsidiary personnel.

This agreement aims to provide comprehensive indemnification to the fullest extent permitted by law, including advancement of expenses, offering enhanced protection to key individuals managing the company and its subsidiaries. Investors should note these actions as they relate to corporate governance and risk management.

Key Highlights

  1. Appointment of Dr. Laura D’Andrea Tyson to the Board of Directors, effective March 4, 2010.
  2. Adoption of a new form of Indemnification Agreement for directors and officers.
  3. The Indemnification Agreement provides indemnification to the fullest extent permitted by law.
  4. The agreement includes provisions for the advancement of expenses for covered individuals.
  5. The filing clarifies existing indemnification provisions and supplements corporate charter protections.
  6. The press release announcing Dr. Tyson's appointment is included as an exhibit.

Frequently Asked Questions

  1. Who is Dr. Laura D’Andrea Tyson and why is her appointment significant?

    Dr. Laura D’Andrea Tyson is a new appointee to CBRE's Board of Directors, with her term commencing on March 4, 2010. While the filing doesn't detail her specific expertise, the addition of new directors often signifies a move to strengthen the board's capabilities, diversify perspectives, or respond to evolving corporate needs. Investors may wish to research her background further for deeper insights into potential strategic contributions.

  2. What does the new Indemnification Agreement entail?

    The newly adopted Indemnification Agreement is designed to offer broad legal protection to CBRE's directors, officers, and certain other key personnel. It generally ensures that these individuals will be indemnified against expenses, judgments, fines, and settlement costs incurred in connection with legal actions related to their roles with the company, to the maximum extent allowed by law. It also provides for the advancement of legal expenses.

  3. Why would CBRE Group implement a new Indemnification Agreement at this time?

    Implementing a comprehensive Indemnification Agreement often reflects a commitment to robust corporate governance and a desire to attract and retain qualified leadership. By providing enhanced legal protections, the company can reassure its directors and officers, especially during potentially challenging economic climates or complex business operations, that they will be supported in the event of legal proceedings arising from their service.

  4. Are there any immediate financial implications of these events?

    This 8-K filing primarily addresses corporate governance and personnel matters. There are no immediate, direct financial statements or results reported that would indicate a change in the company's financial performance. The adoption of the Indemnification Agreement represents a contingent liability for the company, but its financial impact is tied to future events and is intended to provide a framework for covering potential legal costs for covered individuals.